Currently, carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) have been widely used for auxiliary CRC diagnosis and prognostic prediction [8,9]. Here, CEACAM5 is linked to colorectal carcinoma.